ARE

Serial Number 90326909
606

Registration Progress

Application Filed
Nov 18, 2020
Under Examination
Nov 9, 2021
Approved for Publication
Sep 14, 2021
Published for Opposition
Sep 14, 2021
Registered

Trademark Image

ARE

Basic Information

Serial Number
90326909
Filing Date
November 18, 2020
Published for Opposition
September 14, 2021
Abandonment Date
December 16, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 16, 2024
Classes
035 042

Rights Holder

ANDOVER RESEARCH EYE INSTITUTE, LLC

16
Address
300 BRICKSTONE SQUARE
ANDOVER, MA 01810

Ownership History

Ora, Inc.

Original Applicant
03
Andover, MA

Ora, Inc.

Owner at Publication
03
Andover, MA

ANDOVER RESEARCH EYE INSTITUTE, LLC

New Owner After Publication #1
16
ANDOVER, MA

Legal Representation

Attorney
Michael R Rizzo

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description Documents
Dec 16, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 16, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 26, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 12, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 12, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 5, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 3, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 3, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 3, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 10, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 8, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 8, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 8, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 21, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 19, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 19, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 19, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 14, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 14, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 9, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 14, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 26, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 11, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 11, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 11, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Aug 11, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 11, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 20, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 19, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 19, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 31, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 31, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 31, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 31, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 28, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 21, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Information and data compiling and analyzing relating to business management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; compilation and analysis of biostatistics for business or commercial purposes in the field of clinical trials; all of the foregoing excluding real estate services, real estate development, management and maintenance services, real estate rental services, real estate financial services, architecture services, and engineering services
Class 042
medical and scientific research, namely, conducting clinical trials; pharmaceutical drug development services; pharmaceutical testing services

Classification

International Classes
035 042